Advertisement

Topics

Negative immune checkpoint regulation by VISTA: a mechanism of acquired resistance to anti-PD-1 therapy in metastatic melanoma patients

19:11 EDT 4 Aug 2017 | Nature Publishing

Original Article: Negative immune checkpoint regulation by VISTA: a mechanism of acquired resistance to anti-PD-1 therapy in metastatic melanoma patients

NEXT ARTICLE

More From BioPortfolio on "Negative immune checkpoint regulation by VISTA: a mechanism of acquired resistance to anti-PD-1 therapy in metastatic melanoma patients"

Quick Search
Advertisement